Literature DB >> 11212138

A novel in vitro model of tumor angiogenesis.

D Kozien, M Gerol, B Hendey, A RayChaudhury.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11212138     DOI： 10.1007/BF02577521

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


× No keyword cloud information.
  13 in total

Review 1.  Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.

Authors:  D Hanahan; J Folkman
Journal:  Cell       Date:  1996-08-09       Impact factor: 41.582

2.  An in vitro three-dimensional coculture model of cerebral microvascular angiogenesis and differentiation.

Authors:  L R Ment; W B Stewart; D Scaramuzzino; J A Madri
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

3.  Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancers.

Authors:  V Chopra; T V Dinh; E V Hannigan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-06       Impact factor: 2.416

4.  A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin.

Authors:  D J Good; P J Polverini; F Rastinejad; M M Le Beau; R S Lemons; W A Frazier; N P Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

5.  Differential expression of extracellular proteins is correlated with angiogenesis in vitro.

Authors:  M L Iruela-Arispe; P Hasselaar; H Sage
Journal:  Lab Invest       Date:  1991-02       Impact factor: 5.662

6.  Dexamethasone reduces vascular density and plasminogen activator activity in 9L rat brain tumors.

Authors:  J E Wolff; C Guerin; J Laterra; J Bressler; R R Indurti; H Brem; G W Goldstein
Journal:  Brain Res       Date:  1993-02-26       Impact factor: 3.252

7.  Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis.

Authors:  N Sheibani; W A Frazier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1.

Authors:  K M Dameron; O V Volpert; M A Tainsky; N Bouck
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

9.  Comparison of normal and tumorigenic endothelial cells: differences in thrombospondin production and responses to transforming growth factor-beta.

Authors:  A RayChaudhury; W A Frazier; P A D'Amore
Journal:  J Cell Sci       Date:  1994-01       Impact factor: 5.285

10.  Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity.

Authors:  S S Tolsma; O V Volpert; D J Good; W A Frazier; P J Polverini; N Bouck
Journal:  J Cell Biol       Date:  1993-07       Impact factor: 10.539
View more
  2 in total

1.  A microfluidic co-culture system to monitor tumor-stromal interactions on a chip.

Authors:  Nishanth V Menon; Yon Jin Chuah; Bin Cao; Mayasari Lim; Yuejun Kang
Journal:  Biomicrofluidics       Date:  2014-12-05       Impact factor: 2.800

2.  In vitro angiogenesis induced by tumor-endothelial cell co-culture in bilayered, collagen I hydrogel bioengineered tumors.

Authors:  Christopher S Szot; Cara F Buchanan; Joseph W Freeman; Marissa Nichole Rylander
Journal:  Tissue Eng Part C Methods       Date:  2013-04-26       Impact factor: 3.056
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.